Polyneuron Pharmaceuticals' Incubator/Accelerator Round

Polyneuron Pharmaceuticals raised a round of funding on September 18, 2017. Investors include BaseLaunch.

Polyneuron Pharmaceuticals is committed to the development of a new drug class for the treatment of autoimmune disorders. The company's vision is to take immunotherapy to an unprecedented level of sel…

Articles about Polyneuron Pharmaceuticals' Incubator/Accelerator Round: